Tag: Global Health

Health

Dr. Sairaj Phaldessai Appointed as Collaborator in Rural Health by The University of Tokyo

Tanisha Cardozo

In a remarkable development that brings pride to Goa and the Indian medical fraternity, Dr. Sairaj Phaldessai has been appointed as a Collaborator in Rural Health by The University of Tokyo. As part of this prestigious role, Dr. Phaldessai will present papers focused on rural healthcare in India, contributing to global medical discourse and research.

A graduate of Goa Medical College, Dr. Phaldessai is the son of the late Dr. Satish Phaldessai, a respected name in rural medicine. His appointment not only carries forward a legacy of service but also signals a growing international recognition of the work being done in India’s rural healthcare sector.

Through this collaboration, Dr. Phaldessai will bring insights into the challenges faced by rural communities in accessing healthcare—ranging from infrastructure and outreach to cultural and socioeconomic factors. Equally, his work will highlight the innovative grassroots solutions being implemented in Indian villages and semi-urban areas to address these barriers.

This appointment also marks a significant milestone in Dr. Phaldessai’s career, establishing him as a thought leader in rural health and a representative voice from Goa on the global medical stage. His contributions are expected to foster deeper academic exchange between India and Japan, while strengthening the bridge between traditional practices and modern healthcare frameworks.

As Goa continues to make its mark in various professional arenas, Dr. Phaldessai’s recognition underscores the global impact local leaders can have when dedication meets opportunity. His journey serves as an inspiration for young medical professionals committed to healthcare accessibility and innovation.

Health

Molbio Diagnostics Empowers Philippines to Fast-Track TB Elimination with Truenat and Ultra-Portable X-ray Tech

Tanisha Cardozo

Tuberculosis (TB) continues to be one of the Philippines’ most pressing public health challenges, with nearly 190,000 cases going undetected each year. In a transformative move aligned with the UN goal to treat 2.1 million TB cases by 2027, the Philippines Department of Health has embraced Indian innovation to revolutionize its TB response.

At the forefront is the Truenat® platform, a WHO-endorsed, ICMR-approved molecular diagnostic solution developed by Goa-based Molbio Diagnostics. Designed for portability, accuracy, and speed, the Truenat® system supports rapid testing not just for TB, but for a wide array of infectious diseases, including HIV, HPV, and Hepatitis B & C.

Currently, 68 Truenat® devices are operational across the Philippines. A pilot on Bantayan Island yielded a staggering 1008% increase in TB detection — a powerful testament to the platform’s impact.

Geographic barriers, under-resourced labs, and limited rural access have long hindered TB diagnosis in the Philippines. Truenat®, alongside the newly approved PRORAD Atlas Ultraportable X-ray system, now makes it possible to deliver end-to-end screening, diagnosis, and treatment — even in the most isolated communities.

During an official visit to Molbio’s facility in India, Philippines Health Secretary Dr. Teodoro J Herbosa commended the partnership, calling it a “beacon of innovation” and highlighting the broader strategic alliance between the two nations. “Truenat® allows for swift and accurate TB screenings, enhancing our capacity to manage and eventually eliminate TB within our borders,” he said.

This healthcare collaboration reflects a growing Indo-Philippine partnership that now exceeds $3 billion in trade, spanning pharmaceuticals, medical technology, and beyond.

Molbio Diagnostics will further its engagement with the Philippines by hosting a panel at the 31st Philippine Coalition Against Tuberculosis (PhilCAT) Annual Convention in Manila on August 14–15, 2025.

The company’s broader mission continues through projects like a multi-country R2D2 TB Network study exploring tongue-swab molecular testing — a game-changer for TB detection among children and people with HIV/AIDS.

“By bringing diagnostics to the doorstep of underserved communities, we aim to close the TB care gap and help countries build stronger, more resilient health systems,” said Shiva Sriram, President of Molbio Diagnostics.

International

Indian-Origin Physician Dr. Bobby Mukkamala Makes History as 180th President of the American Medical Association

allycaralgoa

Dr. Bobby Mukkamala, a physician of Indian origin, has etched his name in history by becoming the 180th President of the American Medical Association (AMA)—the largest and most influential physician organization in the United States.

This landmark achievement not only highlights Dr. Mukkamala’s commitment to medicine and public health but also underscores the growing global impact of the Indian-American medical community.

Dr. Mukkamala, an otolaryngologist (ENT specialist) from Flint, Michigan, has been a prominent figure in organized medicine for years. As a long-time advocate for both physicians and patients, his work has spanned issues like healthcare access, opioid addiction, medical education, and equitable health policy.

With decades of hands-on clinical experience and leadership roles within the AMA, Dr. Mukkamala is widely respected for bridging the gap between policy and practice. His presidency arrives at a time when the American healthcare system continues to face major transformations post-pandemic.

Dr. Mukkamala’s appointment is particularly meaningful for the global Indian community, reflecting the continued contributions of Indian-origin professionals in leadership roles worldwide.

“It’s an honor to serve at a time when medicine needs strong, inclusive leadership,” Dr. Mukkamala said. “I am committed to advocating for patients, supporting physicians, and driving solutions to the challenges facing our healthcare system.”

As AMA President, Dr. Mukkamala is expected to focus on:

  • 🔹 Addressing physician burnout and workforce shortages
  • 🔹 Advancing equitable access to healthcare
  • 🔹 Advocating for reforms in medical education
  • 🔹 Combating misinformation in medicine
  • 🔹 Supporting evidence-based policy reform

Dr. Bobby Mukkamala earned his medical degree from the University of Michigan and has practiced medicine for over 20 years. In addition to his clinical and advocacy work, he has served on multiple boards, including efforts to combat opioid addiction and improve public health in underserved areas.

Dr. Mukkamala’s rise to AMA’s presidency sends a powerful message: that inclusivity, expertise, and advocacy can transform healthcare systems globally. As he steps into this historic role, the medical community—and indeed, the world—watches with high hopes.

With compassion, clarity, and conviction, Dr. Bobby Mukkamala is poised to lead the AMA into a new era of healthcare leadership.

Global Goans

Dr Roque Pinto Chairs Scientific Sessions at International Cytology Congress in Italy

allycaralgoa

Dr Roque G Wiseman Pinto, renowned Professor of Pathology and former Dean at Goa University, proudly represented India at the prestigious 22nd International Congress of Cytology held in Florence, Italy, from May 11 to 15 at the historic Fortezza da Basso. The global event, jointly organized by the International Academy of Cytology (IAC) and SIAPEC, brought together 750 delegates from 66 countries, including a contingent of 25 Indian participants, highlighting the global collaboration in the evolving field of cytopathology.

Invited as Chairman and Faculty, Dr Pinto was entrusted with leading three key scientific sessions, which focused on:

  • Salivary Gland Cytopathology (Milan System)
  • Cytopathology of Infectious Diseases
  • Fungal Infections in Cytology

Beyond his chairing responsibilities, Dr Pinto was an active participant in several high-level meetings of the IAC (International Academy of Cytology) and the European Federation of Cytology Societies (EFCS), contributing valuable perspectives on behalf of the Indian medical community. Notably, he was also a speaker at the IAC Social Media Symposium, where he addressed the global impact of cytopathology, its advantages over histopathology, and the growing role of digital engagement in India’s pathology landscape.

The congress was led by Dr Fernando Schmitt (Luxembourg) as the Congress President, with Dr Guido Fadda (Italy) heading the Local Organising Committee. Other distinguished Indian faculty members at the event included Dr Radhika S, Dr B Rekhi, and Dr Nalini Gupta, further showcasing India’s prominence in the field.

The conference, accredited by the IAC, EFCS, and the Italian Society of Pathology, served as a vibrant platform for exchange of cutting-edge research, technological innovation, and international collaboration. The next edition of the Congress will be held in South Korea in 2028.

#AllycaralFeature 👒, Fit & Fabulous

World Cancer Day: A Global Call to Action for a Cancer-Free World

allycaralgoa

Written by Intern Joysi Yadav, Team Allycaral

Every year on February 4th, the world comes together to commemorate World Cancer Day, a global awareness day that aims to educate, mobilize, and inspire individuals to take action against cancer.

Cancer is one of the leading causes of death worldwide, affecting not only the patients but also their families and loved ones. Low- and middle-income countries face additional challenges due to lack of awareness, low literacy rates, and limited access to affordable treatment.

World Cancer Day serves as a powerful reminder that we can make a difference in the fight against cancer. By building a cohesive community, inspiring action, and promoting education and awareness, we can work towards a cancer-free world.

World Cancer Day brings people from all walks of life together to discuss cancer, share experiences, and explore ways to diagnose, treat, and prevent the disease. This collective effort helps raise awareness, build empathy, and foster understanding towards cancer patients.

World Cancer Day encourages individuals to contribute to the fight against cancer through fundraising activities, supporting education and research, and advocating for improved health facilities. Every action counts, and collective efforts can lead to significant positive change.


World Cancer Day serves as a platform to educate people about cancer, emphasizing the importance of early detection, adequate treatment, and prevention. By debunking myths and misconceptions, we can empower individuals to make informed decisions about their health.

The theme for World Cancer Day 2025 is “United in Unique,” emphasizing the need for personalized, people-centered care in the fight against cancer. Every individual is unique, with their own needs, perspectives, and challenges. By working together to provide tailored support and treatment, we can make a meaningful difference in the lives of cancer patients and their loved ones.

So, how can you contribute to the fight against cancer? Here are some ways to make a difference:

  • Educate yourself about cancer and its effects
  • Advocate for better health resources and support
  • Participate in community events and fundraising activities
  • Strike a conversation about cancer with friends, family, and colleagues

Every action counts, and collective efforts can lead to significant positive change. Let’s come together to make a difference in the fight against cancer.

World Cancer Day is a powerful reminder that we can make a difference in the fight against cancer. By building a cohesive community, inspiring action, and promoting education and awareness, we can work towards a cancer-free world. Let’s unite in our efforts to make a meaningful difference in the lives of cancer patients and their loved ones.